Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine

Obstetrics and Gynecology

Volumn 127, Issue 2, 2016, Pages 213-221

  Donders, Gilbert G G ^a   Halperin, Scott A ^a   Devlieger, Roland ^a   Baker, Sherryl ^a   Forte, Pietro ^a   Wittke, Frederick ^a   Slobod, Karen S ^a   Dull, Peter M ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; AMPICILLIN; ANTIBIOTIC AGENT; ANTIBODY; BETA LACTAM; DIPHTHERIA TOXOID; INFLUENZA VACCINE; POLYSACCHARIDE VACCINE; STREPTOCOCCUS VACCINE; TETANUS TOXOID; TRIPLE VACCINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; CONFERENCE PAPER; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; GROUP B STREPTOCOCCAL INFECTION; GROUP B STREPTOCOCCAL MENINGITIS; HUMAN; IMMUNIZATION; NEWBORN INFECTION; NEWBORN SEPSIS; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PREGNANT WOMAN; PRIORITY JOURNAL; PROPHYLAXIS; SEROTYPE; TETANUS PROPHYLAXIS; VACCINATION; ADULT; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; IMMUNOLOGY; MULTICENTER STUDY; NEWBORN; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

ADULT; FEMALE; HUMANS; IMMUNIZATION; INFANT, NEWBORN; PREGNANCY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

EID: 84955466065     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001190     Document Type: Conference Paper

References (21)

1. Englund JA. The influence of maternal immunization on infant immune responses. J Comp Pathol 2007;137(suppl 1):S16-9.
2. Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012;2012:985646.
3. Simister NE. Placental transport of immunoglobulin G. Vaccine 2003;21:3365-9.
4. Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 1996;36:248-55.
5. England PH. Pertussis (whooping cough) immunisation for pregnant women. 2013. Available at: http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/WhoopingCough/ImmunisationForPregnantWomen/. Retrieved December 12, 2014.
6. Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993;168:647-56.
7. Melin P. Prevention of perinatal group B streptococcal diseases: Belgian guidelines. Second meeting of the European Infection Control Advisory Panel; 2007. Available at: http://orbi.ulg.ac. be/bitstream/2268/82459/1/03-RT85-ppp.pdf. Retrieved June 17, 2015.
8. Money D, Allen VM; Canadian Paediatric Society, Infectious Diseases Committee. The prevention of early-onset neonatal group B streptococcal disease [in English, French]. J Obstet Gynaecol Can 2004;26:826-40.
9. Hickman ME, Rench MA, Ferrieri P, Baker CJ. Changing epidemiology of group B streptococcal colonization. Pediatrics 1999;104:203-9.
10. Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal group B streptococcal colonization. The Cochrane Database of Systematic Reviews 2014, Issue 6. Art. No.: CD007467. DOI: 10.1002/14651858.CD007467.pub4.
11. Berardi A, Rossi C, Lugli L, Creti R, Bacchi Reggiani ML, Lanari M, et al. Group B streptococcus late-onset disease: 2003-2010. Pediatrics 2013;131:e361-8.
12. Shah BA, Padbury JF. Neonatal sepsis: an old problem with new insights. Virulence 2014;5:170-8.
13. Baker CJ. The spectrum of perinatal group B streptococcal disease. Vaccine 2013;31(suppl 4):D3-6.
14. Shahid NS, Steinhoff MC, Roy E, Begum T, Thompson CM, Siber GR. Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococcal vaccine: a randomized, controlled evaluation. Vaccine 2002; 20:2404-9.
15. Quiambao BP, Nohynek HM, Kayhty H, Ollgren JP, Gozum LS, Gepanayao CP, et al. Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies. Vaccine 2007;25:4470-7.
16. O?Dempsey TJ, McArdle T, Ceesay SJ, Secka O, Demba E, BanyaWA, et al. Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy. Arch Dis Child Fetal Neonatal Ed 1996;74:F43-6.
17. Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-Tetanus toxoid conjugate vaccine. Vaccine 2003;21:3468-72.
18. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group-B streptococcal infection. N Engl J Med 1976;294:753-6.
19. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162-72.
20. Riddell A, Buttery JP, McVernon J, Chatler T, Lane L, Bowen-Morris J, et al. A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide-CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase. Vaccine 2007;25:3906-12.
21. Edmond KM, Kortsalioudaki C, Scott S, Schrag S, Zaidi AK, Cousens S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-Analysis. Lancet 2012;379:547-56.